UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 12, 2019
Accession Number: 0001654954-18-014360
Submission Type: POS AM
CIK: 0001681682
Company Name: ENDRA Life Sciences Inc.
File Number: 333-214724